Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.670
-0.090 (-1.89%)
At close: Aug 10, 2026, 4:00 PM EDT
4.580
-0.090 (-1.93%)
After-hours: Aug 10, 2026, 7:34 PM EDT
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $302.96 million as of August 10, 2026. Its market cap has decreased by -21.77% in one year.
Market Cap
302.96M
Enterprise Value
326.47M
1-Year Change
-21.77%
Ranking
Category
Stock Price
$4.67
ChartMarket Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $302.96M, a decrease of -65.95%. That is a compound annual growth rate of -18.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 302.96M | 94.07% |
| Dec 31, 2025 | 156.11M | -66.32% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 908 Devices | 363.50M |
| Viemed Healthcare | 359.17M |
| Pacific Biosciences of California | 352.79M |
| Electromed | 349.83M |
| Perspective Therapeutics | 338.15M |
| CapsoVision | 336.25M |
| TriSalus Life Sciences | 330.04M |
| Standard BioTools | 306.24M |